This study suggests that ghrelin/GHSR signaling promotes lipid uptake and WAT accumulation via endothelial cells, making this pathway a promising therapeutic target for obesity and dyslipidemia. The gene discussed is GHRL; the disease is obesity due to melanocortin 4 receptor deficiency.